ArticleKidney medicine2026

Subcutaneous Daratumumab in Recurrent Posttransplant Focal Segmental Glomerulosclerosis: A Report of 2 Cases.

Andreja Aleš Rigler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.